Related Experiment Video
Updated: May 19, 2026
08:58
Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
Published on: April 18, 2025
Innate immunity in cystic fibrosis lung disease
1Department of Pediatrics I, University of Tübingen, Tübingen, Germany. dominik.hartl@med.uni-tuebingen.de
Summary
Cystic Fibrosis (CF) lung disease involves early, dysregulated innate immune system activation. Understanding this immune response may lead to new therapies for CF and other chronic lung infections.
Area of Science:
- Immunology
- Pulmonology
- Genetics
Background:
- Chronic lung disease is a primary driver of morbidity and mortality in cystic fibrosis (CF).
- The pulmonary immune environment in CF exhibits persistent, dysregulated innate immune activation.
- Understanding these immune dysregulations is crucial for developing effective CF treatments.
Purpose of the Study:
- To provide a comprehensive overview of the innate immune system's role in cystic fibrosis lung disease.
- To explore the multifaceted aspects of innate immunity in CF, including epithelial dysfunction and immune cell activity.
- To identify potential therapeutic targets within the innate immune pathways for CF.
Main Methods:
- Literature review and synthesis of existing research on innate immunity in CF.
- Analysis of key components of the innate immune response in the context of CF lung disease.
- Examination of mechanisms linking innate and adaptive immunity in CF.
Main Results:
- Innate immune system activation in CF is characterized by early onset and failure to resolve.
- Key areas of dysregulation include epithelial dysfunction, altered pathogen sensing, leukocyte recruitment issues, and impaired phagocyte function.
- Specific mechanisms connecting innate and adaptive immunity in CF were identified.
Conclusions:
- The innate immune system plays a central, dysregulated role in the pathogenesis of CF lung disease.
- Targeting specific innate immune pathways and inflammatory cascades offers potential for novel therapeutic strategies.
- Further research into innate immunity in CF could benefit patients with other chronic infectious lung diseases.
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:29Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...